Ensign Peak Advisors
SYRE icon

Ensign Peak Advisors’s Spyre Therapeutics SYRE Stock Holding History

Ensign Peak Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-82,475
Closed -$1.92M – 1725
2024
Q4 		$1.92M Hold
82,475
– – ﹤0.01% 956
2024
Q3 		$2.43M Hold
82,475
– – ﹤0.01% 867
2024
Q2 		$1.94M Buy
+82,475
New +$1.94M ﹤0.01% 923